Israel - English - Ministry of Health

novartis israel ltd - mitoxantrone as hydrochloride - concentrate for solution for infusion - mitoxantrone as hydrochloride 2 mg/ml - mitoxantrone - mitoxantrone - treatment of advanced breast cancer, non-hodgkin's lymphomas, acute non lymphocytic leukemia palliation of non resectable primary hepatocellular carcinoma. mitoxantrone in combination with corticosterolds is indicated for inital chemotherapy in patients with pain due to advanced hormone-refractory prostate cancer. for reduction of neurologic disability and/or frequency of clinical relapses in patients with secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remmitting multiple sclerosis (patients whose neurologic status is significantly abnormal between relapses), for patients 18-55 years old.בקשה לשינוי התוויה: 5/1/2021mitoxantrone is indicated in the treatment of metastatic breast cancer.mitoxantrone is indicated in the treatment of non-hodgkin’s lymphoma.mitoxantrone is indicated for the treatment of acute myeloid leukaemia (aml) in adults.mitoxantrone in combination regimens is indicated in the remission-induction treatment of blast crisis in chronic myeloid leukaemia.mitoxantrone is indicated in combination with corticosteroids for palliation (e.g. pain relief) related to advanced castrate resistant prostate cancer.mitoxantrone is indicated for treatment of patients with highly active relapsing multiple sclerosis associated with rapidly evolving disability where no alternative therapeutic options exist.

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira uk limited - mitoxantrone hydrochloride - concentrate for soln for inf - 2 base mg/ml - anthracyclines and related substances

Malta - English - Medicines Authority

ebewe pharma gmbh nfg. kg mondseestrasse 11, 4866 unterach, austria - mitoxantrone - concentrate for solution for infusion - mitoxantrone 2 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare limited - mitoxantrone - concentrate for solution for infusion - mitoxantrone 10 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare limited - mitoxantrone - concentrate for solution for infusion - mitoxantrone 20 mg - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare limited - mitoxantrone - concentrate for solution for infusion - mitoxantrone 30 mg - antineoplastic agents

Malta - English - Medicines Authority

central procurement & supplies unit - mitoxantrone - solution for infusion - mitoxantrone 2 milligram(s)/millilitre - antineoplastic agents

Malta - English - Medicines Authority

baxter healthcare limited caxton way, thetford, norfolk ip24 3se, united kingdom - mitoxantrone - concentrate for solution for infusion - mitoxantrone 2 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

strides arcolab international limited - mitoxantrone 2 mg/ml - concentrate for solution for infusion

Canada - English - Health Canada

lederle cyanamid canada inc. - mitoxantrone (mitoxantrone hydrochloride) - liquid - 2mg - mitoxantrone (mitoxantrone hydrochloride) 2mg - antineoplastic agents